Overview
Terence Friedlander is a Hematologist practicing medicine in San Francisco, California.
Dr. Friedlander is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Upper Tract Urothelial Carcinoma (UTUC), ALK-Positive Non-Small Cell Lung Cancer, and Prostatectomy.
He is actively involved in clinical research, co-authoring 87 peer reviewed articles and participating in 7 clinical trials.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
Accepted plan types not found. Please verify directly with the provider.
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1825 4th St # 6, San Francisco, CA 94143
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
7 Clinical Trials
Head And Neck Medical Oncology Program
Dr. Alain Algazi is a specialist in medical treatment – such as chemotherapy and immunotherapy – for patients with head and neck cancers, including head and neck squamous cell carcinoma, thyroid cancers and salivary gland cancers. He leads UCSF's program in medical therapy for head and neck cancers, and chairs the head and neck cancer research committee. In research, Algazi conducts clinical trials – studies that evaluate new therapies for head and neck cancers with an emphasis on approaches to improving the chances of long term remission in patients with incurable cancer using immunotherapy. He has also served the national study chair for clinical trials that give patients access to new medications and that provide new approaches of administering existing medications to improve their efficacy. Algazi earned his medical degree from the David Geffen School of Medicine at UCLA and completed a residency in internal medicine at Ronald Reagan UCLA Medical Center. He completed a fellowship in hematology-oncology at UCSF. Algazi is a member of the American Society of Clinical Oncology, Society for Immunotherapy for Cancer and American Association for Cancer Research. To reach Dr. Alain Algazi, please contact the head and neck medical oncology practice at (415) 353-9900. Dr. Algazi is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Melanoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Polymorphous Low Grade Adenocarcinoma, and Glioma. Dr. Algazi is board certified in American Board Of Internal Medicine, Medical Oncology. Dr. Algazi is currently accepting new patients.
Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program
Aaron Logan is a Hematologist practicing medicine in San Francisco, California. Dr. Logan is highly rated in 32 conditions, according to our data. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Graft Versus Host Disease (cGvHD), Bone Marrow Aspiration, and Bone Marrow Transplant.
Hereditary Cancer Clinic
Dr. Pamela N. Munster is a medical oncologist who cares for patients with breast cancer. Her roles include director of the early-phase clinical trials program for cancer research; co-director of the UCSF Center for BRCA Research; and co-leader of UCSF's program in developmental therapeutics, which focuses on innovative research to find treatments for advanced cancer. In her own research endeavors, Munster is interested in developing new targeted therapies for treatment-resistant cancer. She studies changes in gene expression and resistance to therapy. Her lab is involved in projects evaluating hormone therapies for breast cancer as well as therapies that engage the immune system to fight tumors. She has published in numerous scientific journals and lectured on topics in breast oncology, such as the management of metastatic breast cancer, breast cancer receptors, clinical trials and translational research (the process of applying study findings to patient care). She has a published memoir, “Twisting Fate: My Journey with BRCA – From Breast Cancer Doctor to Patient and Back.” Munster earned her medical degree from the University of Bern in Switzerland. She completed a residency in internal medicine at Indiana University Health, followed by a fellowship in medical hematology and oncology at Memorial Sloan Kettering Cancer Center, where she also served as faculty in the breast cancer program. Prior to joining UCSF, Munster worked for six years in the Moffitt Cancer Center's division of breast oncology and experimental therapeutics program, serving as scientific director of breast research and co-chair of the phase 1 clinical trial program. Dr. Munster is highly rated in 28 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER2 Negative Breast Cancer, BRCA Positive Breast Cancer, Prostatectomy, and Liver Embolization. Dr. Munster is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Munster is currently accepting new patients.
Melanoma & Skin Cancer Center
Dr. Adil Daud, an oncologist, specializes in melanoma and other skin cancers. He is co-director of the Melanoma Center. In addition to caring for patients, he directs research to better understand the biology of melanoma and to develop new treatments. He has developed and led many clinical trials that have expanded the use of gene therapy for melanoma. Daud earned a medical degree at the Government Medical College, Nagpur. He completed both an internship and a residency in internal medicine at Indiana University School of Medicine, followed by a fellowship in hematology-oncology at Memorial Sloan Kettering Cancer Center. Prior to joining UCSF Medical Center, he was a researcher at the Moffitt Cancer Center in Tampa, Florida, for seven years. Daud has won numerous awards, including a Young Investigator Award from the American Society of Clinical Oncology and selection as a Castle Connolly Top Doctor. Dr. Daud is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Melanoma of the Eye, and Neuroendocrine Tumor. Dr. Daud is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology and American Board Of Internal Medicine, Internal Medicine. Dr. Daud is currently accepting new patients.
Hemophilia Treatment Center
Andrew Leavitt is a Hematologist practicing medicine in San Francisco, California. Dr. Leavitt is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Hemophilia A, Von Willebrand Disease (VWD), Blood Clots, Bone Marrow Aspiration, and Splenectomy.
Office
Ari Baron is a Hematologist and an Oncologist practicing medicine in San Francisco, California. Dr. Baron is highly rated in 64 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Pancreatic Cancer, Liver Cancer, Familial Colorectal Cancer, and Bone Marrow Aspiration.
Frequently Asked Questions about Dr. Terence W. Friedlander
How do I make an appointment with Dr. Terence W. Friedlander?
You can book an appointment with Dr. Terence W. Friedlander by calling their office at 415-476-4616. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Terence W. Friedlander a top-rated expert for Muscle Invasive Bladder Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Terence W. Friedlander is classified as an Distinguished expert for Muscle Invasive Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Terence W. Friedlander specialize in?
While Dr. Terence W. Friedlander is a Hematology, they have specific expertise in Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, and Upper Tract Urothelial Carcinoma (UTUC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Terence W. Friedlander participate in research or clinical trials?
Yes. Dr. Terence W. Friedlander has published 87 articles and abstracts on conditions like Muscle Invasive Bladder Cancer. You can view a list of Dr. Terence W. Friedlander's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Terence W. Friedlander accept my insurance?
Dr. Terence W. Friedlander accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 415-476-4616 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Muscle Invasive Bladder CancerDr. Friedlander isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerDr. Friedlander isDistinguished. Learn about Non-Muscle Invasive Bladder Cancer.
- Advanced
- Upper Tract Urothelial Carcinoma (UTUC)Dr. Friedlander isAdvanced. Learn about Upper Tract Urothelial Carcinoma (UTUC).
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Friedlander isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Febrile NeutropeniaDr. Friedlander isExperienced. Learn about Febrile Neutropenia.
- Multiple MyelomaDr. Friedlander isExperienced. Learn about Multiple Myeloma.
- ProstatectomyDr. Friedlander isExperienced. Learn about Prostatectomy.
- Smoldering Multiple MyelomaDr. Friedlander isExperienced. Learn about Smoldering Multiple Myeloma.
- Squamous Cell Carcinoma of the Anal Canal (SCAC)Dr. Friedlander isExperienced. Learn about Squamous Cell Carcinoma of the Anal Canal (SCAC).


